MageA1-TCR Gene Therapy of Multiple Myeloma / Medigene, Max Delbrück Centre for Molecular Medicine, Charite - University of Medicine Berlin - LARVOL DELTA

Selection of affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10 (AACR 2018) - P1; "The X-scan method permitted us to select the most specific and potent candidate for further pre-clinical testing. This MAGE-A10TCR is now being studied in clinical trials to treat HLA-A2+ patients with non-small cell lung cancer, urothelial cancers, melanoma, or head and neck cancers."

IO Biomarker • Bladder Cancer • Head and Neck Cancer • Melanoma • Non Small Cell Lung Cancer